[Treatment of pulmonary embolism].
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin
Tratamiento del tromboembolismo pulmonar.